TABLE 2.
Tumor Characteristics in the 2 Different Patient Preparation Groups
| Gleason score* | T stage† | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | GS 5 | GS 6 | GS 7a | GS 7b | GS 8 | GS 9 | GS 10 | T1 | T2 | T3 | T4 |
| G1‡ (%) | 0 (0.0%) | 17 (8.9%) | 62 (32.5%) | 35 (18.3%) | 30 (15.7%) | 47 (24.6%) | 0 (0.0%) | 2 (1.3%) | 57 (36.1%) | 85 (53.8%) | 14 (8.9%) |
| G2¶ (%) | 2 (1.0%) | 17 (18.1%) | 76 (36.2%) | 45 (21.4%) | 30 (14.3%) | 39 (18.6%) | 1 (0.5%) | 4 (2.4%) | 63 (37.3%) | 100 (59.2%) | 2 (1.2%) |
*
Missing data (G1 n = 29; G2 n = 10).
†
Missing data (G1 n = 62; G2 n = 51).
‡
No preparation.
¶
Injection of 20 mg of furosemide and 500 mL of NaCl 0.9%.
P value from Fisher exact tests. Overall P value for Gleason score was 0.531, and overall P value for T stage was 0.008.